Literature DB >> 26110224

Effects of acute and chronic social defeat stress are differentially mediated by the dynorphin/kappa-opioid receptor system.

Rachel J Donahue1, Samantha M Landino, Sam A Golden, F Ivy Carroll, Scott J Russo, William A Carlezon.   

Abstract

Accumulating evidence indicates that kappa-opioid receptors (KORs) and their endogenous ligand, dynorphin (DYN), can play important roles in regulating the effects of stress. Here, we examined the role of KOR systems in the molecular and behavioral effects of acute (1-day) and chronic (10-day) social defeat stress (SDS) in mice. We found that acute SDS increased DYN mRNA levels within the nucleus accumbens, a key element of brain dopamine (DA) systems. In contrast, chronic SDS produced long-lasting decreases in DYN mRNA levels. We then examined whether disruption of KOR function would affect development of SDS-induced depressive-like behaviors, as measured in the intracranial self-stimulation and social interaction tests. Ablation of KORs from DA transporter-expressing neurons delayed the development of SDS-induced anhedonia in the intracranial self-stimulation test, suggesting increased stress resilience. However, administration of the long-lasting KOR antagonist JDTic (30 mg/kg, intraperitoneally) before the SDS regimen did not affect anhedonia, suggesting that disruption of KOR function outside DA systems can oppose stress resilience. Social avoidance behavior measured after the 10-day SDS regimen was not altered by ablation of KORs in DA transporter-expressing neurons or by JDTic administration before testing. Our findings indicate that KORs expressed in DA systems regulate the effects of acute, but not chronic, social stress.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26110224      PMCID: PMC4586263          DOI: 10.1097/FBP.0000000000000155

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  51 in total

1.  DeltaFosB in brain reward circuits mediates resilience to stress and antidepressant responses.

Authors:  Vincent Vialou; Alfred J Robison; Quincey C Laplant; Herbert E Covington; David M Dietz; Yoshinori N Ohnishi; Ezekiell Mouzon; Augustus J Rush; Emily L Watts; Deanna L Wallace; Sergio D Iñiguez; Yoko H Ohnishi; Michel A Steiner; Brandon L Warren; Vaishnav Krishnan; Carlos A Bolaños; Rachael L Neve; Subroto Ghose; Olivier Berton; Carol A Tamminga; Eric J Nestler
Journal:  Nat Neurosci       Date:  2010-05-16       Impact factor: 24.884

2.  Effects of striatal ΔFosB overexpression and ketamine on social defeat stress-induced anhedonia in mice.

Authors:  Rachel J Donahue; John W Muschamp; Scott J Russo; Eric J Nestler; William A Carlezon
Journal:  Biol Psychiatry       Date:  2014-01-08       Impact factor: 13.382

Review 3.  Role of kappa-opioid receptors in stress and anxiety-related behavior.

Authors:  Ashlee Van't Veer; William A Carlezon
Journal:  Psychopharmacology (Berl)       Date:  2013-07-09       Impact factor: 4.530

4.  Survival of DA neurons is independent of CREM upregulation in absence of CREB.

Authors:  R Parlato; C Rieker; M Turiault; F Tronche; G Schütz
Journal:  Genesis       Date:  2006-10       Impact factor: 2.487

5.  Further evidence for the implication of a kappa-opioid receptor mechanism in the production of psychological stress-induced analgesia.

Authors:  M Takahashi; T Senda; S Tokuyama; H Kaneto
Journal:  Jpn J Pharmacol       Date:  1990-08

6.  Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens.

Authors:  A M Pliakas; R R Carlson; R L Neve; C Konradi; E J Nestler; W A Carlezon
Journal:  J Neurosci       Date:  2001-09-15       Impact factor: 6.167

7.  Cellular sites for dynorphin activation of kappa-opioid receptors in the rat nucleus accumbens shell.

Authors:  A L Svingos; E E Colago; V M Pickel
Journal:  J Neurosci       Date:  1999-03-01       Impact factor: 6.167

8.  Ablation of kappa-opioid receptors from brain dopamine neurons has anxiolytic-like effects and enhances cocaine-induced plasticity.

Authors:  Ashlee Van't Veer; Anita J Bechtholt; Sara Onvani; David Potter; Yujun Wang; Lee-Yuan Liu-Chen; Günther Schütz; Elena H Chartoff; Uwe Rudolph; Bruce M Cohen; William A Carlezon
Journal:  Neuropsychopharmacology       Date:  2013-02-27       Impact factor: 7.853

9.  Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats.

Authors:  R Bals-Kubik; A Ableitner; A Herz; T S Shippenberg
Journal:  J Pharmacol Exp Ther       Date:  1993-01       Impact factor: 4.030

Review 10.  Brain dopamine and reward.

Authors:  R A Wise; P P Rompre
Journal:  Annu Rev Psychol       Date:  1989       Impact factor: 24.137

View more
  26 in total

Review 1.  The impact of sex as a biological variable in the search for novel antidepressants.

Authors:  Alexia V Williams; Brian C Trainor
Journal:  Front Neuroendocrinol       Date:  2018-05-31       Impact factor: 8.606

2.  Reduced nucleus accumbens enkephalins underlie vulnerability to social defeat stress.

Authors:  Hyungwoo Nam; Ramesh Chandra; T Chase Francis; Caroline Dias; Joseph F Cheer; Mary Kay Lobo
Journal:  Neuropsychopharmacology       Date:  2019-05-27       Impact factor: 7.853

3.  A Central Extended Amygdala Circuit That Modulates Anxiety.

Authors:  Sandra Ahrens; Melody V Wu; Alessandro Furlan; Ga-Ram Hwang; Raehum Paik; Haohong Li; Mario A Penzo; Jessica Tollkuhn; Bo Li
Journal:  J Neurosci       Date:  2018-05-29       Impact factor: 6.167

4.  The long-term effects of stress and kappa opioid receptor activation on conditioned place aversion in male and female California mice.

Authors:  Abigail R Laman-Maharg; Tiffany Copeland; Evelyn Ordoñes Sanchez; Katharine L Campi; Brian C Trainor
Journal:  Behav Brain Res       Date:  2017-06-15       Impact factor: 3.332

5.  Acute inhibition of kappa opioid receptors before stress blocks depression-like behaviors in California mice.

Authors:  Alexia V Williams; Abigail Laman-Maharg; Crystal V Armstrong; Stephanie Ramos-Maciel; Vanessa A Minie; Brian C Trainor
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2018-06-04       Impact factor: 5.067

Review 6.  A Motivational and Neuropeptidergic Hub: Anatomical and Functional Diversity within the Nucleus Accumbens Shell.

Authors:  Daniel C Castro; Michael R Bruchas
Journal:  Neuron       Date:  2019-05-08       Impact factor: 17.173

7.  Early-Life Social Isolation Stress Increases Kappa Opioid Receptor Responsiveness and Downregulates the Dopamine System.

Authors:  Anushree N Karkhanis; Jamie H Rose; Jeffrey L Weiner; Sara R Jones
Journal:  Neuropsychopharmacology       Date:  2016-02-10       Impact factor: 7.853

Review 8.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

Review 9.  Kappa-Opioid Antagonists for Psychiatric Disorders: From Bench to Clinical Trials.

Authors:  William A Carlezon; Andrew D Krystal
Journal:  Depress Anxiety       Date:  2016-10       Impact factor: 6.505

10.  Activation of kappa opioid receptors in the dorsal raphe have sex dependent effects on social behavior in California mice.

Authors:  Emily C Wright; Tiffany V Parks; Jonathon O Alexander; Rajesh Supra; Brian C Trainor
Journal:  Behav Brain Res       Date:  2018-06-07       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.